AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clouston, J. E.
Right arrow Articles by Zitnay, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clouston, J. E.
Right arrow Articles by Zitnay, K. M.

American Journal of Neuroradiology, Vol 16, Issue 1 27-38, Copyright © 1995 by American Society of Neuroradiology


ARTICLES

Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage

JE Clouston, Y Numaguchi, GH Zoarski, EF Aldrich, JM Simard and KM Zitnay
Department of Radiology, University of Maryland Medical System, Baltimore.

PURPOSE: To evaluate the techniques and efficacy of intracranial intraarterial papaverine infusion for symptomatic vasospasm after subarachnoid hemorrhage caused by aneurysm rupture. METHODS: Papaverine was infused on 19 occasions in 14 patients, 6 hours to 2 days after spasm became apparent clinically. Sixty vascular territories were treated. Infusion was made into the supraclinoid internal carotid artery 20 times, cavernous internal carotid artery once, selective A1 anterior cerebral artery 8 times, M1 middle cerebral artery 7 times, and basilar artery 3 times. Papaverine doses ranged from 150 to 600 mg and exceeded 400 mg on 8 occasions. RESULTS: Angiographic improvement occurred in 18 (95%) of the 19 treatment sessions: results were excellent in 3 sessions, moderate in 8, and mild in 7. The best angiographic results often were obtained with superselective infusion, although angiographic results did not always correlate with clinical response. Seven (50%) of the 14 treated patients showed dramatic acute clinical improvement within 24 hours of papaverine therapy, and there was no clinical evidence of recurrent vasospasm in these patients. Recurrence of angiographic vasoconstriction was demonstrated in three patients; one showed marked clinical improvement after a second treatment. There were no episodes of systemic hypotension in any of the cases. Monocular blindness developed in one patient because of papaverine infusion near the ophthalmic artery. CONCLUSIONS: Papaverine was effective in dilating narrowed arteries in most patients with symptomatic vasospasm caused by subarachnoid hemorrhage. This series showed encouraging clinical results with no recurrence of neurologic deterioration in those patients who responded well to papaverine. Superselective infusion appears to be indicated in some cases for adequate papaverine delivery.


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
S. Reddy, D. R. Goldman, A. Kaines, J.-P. Hubschman, and D. Sarraf
Intracisternal Irrigation of Papaverine Leading to Choroidal Infarction
Arch Ophthalmol, November 1, 2009; 127(11): 1550 - 1551.
[Full Text] [PDF]


Home page
StrokeHome page
J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Stroke, March 1, 2009; 40(3): 994 - 1025.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
G. P. Rath, Mukta, H. Prabhakar, H. H. Dash, and A. Suri
Haemodynamic changes after intracisternal papaverine instillation during intracranial aneurysmal surgery
Br. J. Anaesth., December 1, 2006; 97(6): 848 - 850.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. S. Smith, C. F. Dowd, S. C. Johnston, N. U. Ko, S. J. DeArmond, W. P. Dillon, D. Setty, M. T. Lawton, W. L. Young, R. T. Higashida, et al.
Neurotoxicity of Intra-arterial Papaverine Preserved with Chlorobutanol Used for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Stroke, November 1, 2004; 35(11): 2518 - 2522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Biondi, G. K. Ricciardi, L. Puybasset, L. Abdennour, M. Longo, J. Chiras, and R. Van Effenterre
Intra-Arterial Nimodipine for the Treatment of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Preliminary Results
AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 1067 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Mechanical and Pharmocologic Treatment of Vasospasm
AJNR Am. J. Neuroradiol., September 1, 2001; 22(2007): 26S - 27S.
[Full Text] [PDF]


Home page
StrokeHome page
P. Vajkoczy, P. Horn, C. Bauhuf, E. Munch, U. Hubner, D. Ing, C. Thome, C. Poeckler-Schoeninger, H. Roth, and P. Schmiedek
Effect of Intra-Arterial Papaverine on Regional Cerebral Blood Flow in Hemodynamically Relevant Cerebral Vasospasm
Stroke, February 1, 2001; 32(2): 498 - 505.
[Abstract] [Full Text] [PDF]